bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022)
bioAffinity Technologies (BIAF) posted quarterly Convertible Debt of $325000.0 for Q4 2022, down 87.5% YoY from $2.6 million in Q4 2021, and down 87.5% sequentially from $2.6 million in Q3 2022.
bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022) Analysis & Trends
bioAffinity Technologies has disclosed Convertible Debt across 2 years of filings, most recently posting $325000.0 for Q4 2022.
- In Q4 2022, Convertible Debt fell 87.5% year-over-year to $325000.0; the TTM figure through Dec 2022 stood at $325000.0 (down 87.5% YoY), while the FY2022 annual figure was $325000.0, down 87.5% from the prior year.
- Convertible Debt retreated to $325000.0 in Q4 2022, from $2.6 million in the prior quarter.
- Over the last five years, Convertible Debt for BIAF reached as high as $2.6 million in Q4 2021 and fell as low as $325000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 900,000.00 |